Treatment of severe hidradenitis suppurativa with infliximab in combination with surgical interventions.
D C
DC
Van Rappard
J R
JR
Mekkes
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001799:Blood Sedimentation; D002081:Buttocks; D002097:C-Reactive Protein / Q000378:metabolism; D003131:Combined Modality Therapy / Q000379:methods; D003879:Dermatologic Agents / Q000627:therapeutic use*; D017497:Hidradenitis Suppurativa / Q000188:drug therapy* / Q000601:surgery*; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D055815:Young Adult
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D002097:C-Reactive Protein; D000069285:Infliximab